Every year, almost 200 million people are infected with malaria, and in 2013, an estimated 584,000 people died from the disease. But the international public health community is turning the tide: Thanks to concerted global action and investment, more than 4.3 million lives have been saved since 2000, and death rates among young children have been halved. However, the issue of growing resistance to public health insecticides could threaten the progress of recent years.
There are currently only four classes of insecticides available for adult mosquito control in public health, and the number of species developing resistance to them is on the rise. BASF is working with international public health partners to develop a new generation of malaria prevention products to help address this challenge.
Among others, BASF is working with the World Health Organization (WHO) and the Bill and Melinda Gates Foundation, to bring two new resistance management products based on chlorfenapyr, a completely new active ingredient for the public health sector, to the market. Currently Sylando® 240SC, an indoor residual spray to coat walls and ceilings of homes, and a new generation of BASF’s Interceptor® mosquito nets, called Interceptor® G2, are undergoing trials through the WHO Pesticide Evaluation Scheme (WHOPES).